Chemveda Life Sciences to invest Rs 150 cr for expansion in Hyderabad

Chemveda Life Sciences is a Hyderabad and San Diego headquartered mid-sized contract research organisation which provides solutions to the pharmaceutical, biotechnology and agrochemical industries

KT Rama Rao
The announcement was made after Telangana's Industry Minister K.T. Rama Rao, who is on a visit to the United States, met the company heads in San Diego on Monday
IANS Hyderabad
2 min read Last Updated : Mar 22 2022 | 7:18 AM IST

Chemveda Life Sciences has announced that it will invest Rs 150 crore for the expansion of its footprint in Hyderabad.

The announcement was made after Telangana's Industry Minister K.T. Rama Rao, who is on a visit to the United States, met the company heads in San Diego on Monday.

Chemveda Life Sciences is a Hyderabad and San Diego headquartered mid-sized contract research organisation which provides solutions to the pharmaceutical, biotechnology and agrochemical industries, along with the academia.

In the last five years, with two R&D sites, an area of over 65,000 sq ft and a manufacturing facility spread across eight acres, Chemveda Life Sciences has expanded from 45 employees in 2017 to over 450 employees now.

It will invest an additional Rs 150 crore to add a state-of-the-art R&D centre in Hyderabad, creating additional employment for 500 scientists.

It has already received a funding of Rs 90 crore and another Rs 60 crore funding has been committed. The company announced that it will add a GMP facility with a 200 KL capacity.

K.T Rama Rao said that he was delighted to see the industry benefiting from the active research ecosystem, progressive government policies, and abundant talent pool in Hyderabad.

"Hyderabad is one of the most preferred global destinations for pharma and biotech companies to seek contract research support. We feel privileged to be a part of one of the most cost-competitive and extensive ecosystems to run life sciences R&D," said Bheema Rao Paraselli, President and CEO, Chemveda.

--IANS

ms/arm

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :K T Rama RaoHyderabadTelangana

First Published: Mar 22 2022 | 7:18 AM IST

Next Story